Live Birth More Likely in ART Cycles With Gestational Carrier
THURSDAY, Oct. 19, 2023 (HealthDay News) — The likelihood of live birth is increased among assisted reproductive technology cycles with versus without a gestational carrier, according to a research letter published online Oct. 18 in the Journal of th…
Learn MoreEarlier Diagnosis of Type 2 Diabetes Linked to Lower Life Expectancy
THURSDAY, Oct. 19, 2023 (HealthDay News) — Every decade of earlier diagnosis of type 2 diabetes is associated with a lower life expectancy, according to a study published online Sept. 11 in The Lancet Diabetes & Endocrinology.Stephen Kaptoge, Ph.D., …
Learn MoreRosuvastatin, Atorvastatin Have Comparable Efficacy for CAD
THURSDAY, Oct. 19, 2023 (HealthDay News) — Rosuvastatin and atorvastatin have comparable efficacy for a composite outcome in adults with coronary artery disease, according to a study published online Oct. 18 in The BMJ.Yong-Joon Lee, M.D., from the Y…
Learn MoreSeptoplasty Effective for Nasal Obstruction Linked to Deviated Septum
THURSDAY, Oct. 19, 2023 (HealthDay News) — For adults with nasal obstruction associated with a deviated nasal septum, septoplasty is a more effective intervention than a defined medical management regimen, according to a study published online Oct. 1…
Learn MoreInduced Abortion in First Trimester Not Linked to Rh Sensitization
THURSDAY, Oct. 19, 2023 (HealthDay News) — Induced first-trimester abortion is not associated with Rh sensitization, according to a study published online Sept. 26 in the Journal of the American Medical Association.Sarah Horvath, M.D., from Penn Stat…
Learn MoreCell-Free DNA Methylation Liquid Biopsy Discriminates Ovarian Cancer
THURSDAY, Oct. 19, 2023 (HealthDay News) — A classifier based on cell-free DNA (cfDNA) methylation liquid biopsy can discriminate high-grade serous ovarian carcinoma (HGSOC) from benign masses, according to a study published online Oct. 9 in Clinical…
Learn MoreIDSA: Piperacillin-Tazobactam, Cefepime Comparable for Suspected Infection
THURSDAY, Oct. 19, 2023 (HealthDay News) — For hospitalized patients with suspected infection for whom a clinician initiated an order for antipseudomonal antibiotics within 12 hours of presentation to the hospital, the incidence of acute kidney injur…
Learn MoreIDSA: A. Baumannii, C. Auris Common for Recipients of Mechanical Ventilation
THURSDAY, Oct. 19, 2023 (HealthDay News) — For patients receiving mechanical ventilation, Acinetobacter baumannii and Candida auris are common, with an increased likelihood of colonization among those in long-term care facilities versus acute care ho…
Learn MorePositive Link Identified Between SARS-CoV-2 and Guillain-Barré
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — There is a positive association for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and Guillain-Barré syndrome (GBS), and a negative association for COVID-19 vaccination and GBS, acc…
Learn MoreEnzalutamide + Leuprolide Top for Mets-Free Survival in Prostate Cancer
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — For patients with prostate cancer with high-risk biochemical recurrence, enzalutamide plus leuprolide is best for metastasis-free survival, according to a study published in the Oct. 19 issue of the New Eng…
Learn More